Duality Advisers’s Amedisys AMED Stock Holding History

Duality Advisers’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,234	Closed	-$1.27M	–	543
2022 Q4	$1.27M	Buy	+15,234	New	+$1.37M	0.14%	255
2022 Q2	–	Sell	-1,415	Closed	-$244K	–	591
2022 Q1	$244K	Buy	+1,415	New	+$211K	0.03%	583
2021 Q4	–	Sell	-30,155	Closed	-$4.5M	–	482
2021 Q3	$4.5M	Buy	+30,155	New	+$6.27M	0.34%	97
2021 Q2	–	Sell	-2,971	Closed	-$787K	–	522
2021 Q1	$787K	Buy	+2,971	New	+$838K	0.07%	386
2020 Q4	–	Sell	-1,970	Closed	-$466K	–	542
2020 Q3	$466K	Sell	1,970 -3,434	-64%	-$781K	0.03%	482
2020 Q2	$1.07M	Buy	+5,404	New	+$1.01M	0.1%	243
2019 Q4	–	Sell	-6,250	Closed	-$819K	–	372
2019 Q3	$819K	Buy	+6,250	New	+$814K	0.05%	260

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Duality Advisers's AMED Position: Q1 2023 in Review

Duality Advisers sold out of Amedisys (AMED) in Q1 2023, closing a stake of 15,234 shares — an estimated $1.27M sold.

Duality Advisers first reported a position in AMED in Q3 2019 and held it in 7 quarters. The position peaked at $4.5M in Q3 2021. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

Duality Advisers reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
Duality Advisers sold 15,234 Amedisys shares in Q1 2023, an estimated $1.27M.
Duality Advisers first reported a position in Amedisys in Q3 2019 and held it in 7 quarters.
Duality Advisers's Amedisys position peaked at $4.5M in Q3 2021.
281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Duality Advisers's 13F filing for Q1 2023, filed 27 Jun 2023.